Cancer Research: The lessons to learn from COVID-19

Abstract

The COVID-19 pandemic has caused widespread disruption of cancer clinical trials due to the restrictions on non-essential services and the re-allocation of resources, and at the same time the urgent global effort towards discovering therapies that treat or prevent COVID-19 infection has led to shortening of traditional regulatory timelines. This experience should stimulate similar urgency in the way future cancer research is conducted.

Journal details

Pages Epub ahead of print
Available online
Publication date